Rexahn Pharmaceuticals Presents Preliminary Safety and Efficacy Data From Ongoing Phase 2a Clinical Trial Pharmaceutical Investing
Clementia Initiates Phase 1 Clinical Trial of Palovarotene Eye Drop Formulation in Healthy Volunteers Pharmaceutical Investing
Harvest One Adds Another Vertical Through First Investment in Private Cannabis Retailer Cannabis Investing News
Foamix Announces Additional Positive Topline Results from Third Phase 3 Trial Evaluating FMX101 Life Science Investing
Dermira’s QBREXZA (glycopyrronium) Cloth Is Now Available in Pharmacies Nationwide Pharmaceutical Investing
Antares Receives FDA Approval of Xyosted (Testosterone Enanthate) Injection for Testosterone Replacement Therapy Pharmaceutical Investing
Harvest One Expands National Retail Presence with Manitoba Supply Agreement and Becomes a Registered Supplier in Saskatchewan Cannabis Investing News
Canntab Enters LOI for Bi-Lateral Sales & Distribution and Cannabis Oil Supply Cannabis Investing News
Avadel Pharmaceuticals Announces Journal of Urology Publication of Phase 3 Data on NOCTIVA Pharmaceutical Investing
Intra-Cellular Therapies Completes Submission of New Drug Application for Lumateperone for Treatment of Schizophrenia Pharmaceutical Investing
